Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Toward a treatment for dementia]

J Ghika1

  • 1Service de neurologie, Centre hospitalier universitaire vaudois, Lausanne.

Praxis
|September 19, 1995
PubMed
Summary

Current dementia treatments manage symptoms, not causes. Understanding neuronal death in neurodegenerative disorders is crucial for developing effective preventive or curative therapies for untreatable dementias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic advances in neurology].

Revue medicale suisse·2011
Same author

[Restless legs syndrome in the elderly: an unrecognized disorder].

Revue medicale suisse·2008
Same author

[Movement disorders in stroke].

Revue neurologique·2008
Same author

Paleoneurology: neurodegenerative diseases are age-related diseases of specific brain regions recently developed by Homo sapiens.

Medical hypotheses·2008
Same author

Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect.

Parkinsonism & related disorders·2007
Same author

Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.

Neurology·2007

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Context:

  • Dementias are characterized by progressive neuronal dysfunction and death.
  • Current therapeutic strategies primarily manage symptoms rather than addressing underlying causes.
  • Existing treatments offer limited efficacy, with only marginal benefits observed in early stages.

Purpose:

  • To highlight the critical need for understanding the mechanisms of neuronal vulnerability and death in neurodegenerative disorders.
  • To underscore the limitations of current dementia treatments.
  • To identify promising future therapeutic avenues.

Summary:

  • The clinical manifestations of dementias stem from neuronal dysfunction leading to premature neuronal death.
  • Effective treatments for neurodegenerative disorders are contingent upon elucidating the causes of neuronal vulnerability.
  • Current interventions focus on palliative care or neurotransmitter substitution, yielding minimal success; novel approaches like growth factors show promise.

Impact:

  • Advances in understanding neuronal death mechanisms are essential for developing curative dementia treatments.
  • Future research directions include clinical trials for muscarinic agonists and antiamyloid substances.
  • Nerve growth factors (NGF) represent a significant preclinical hope for future neurodegenerative disease therapies.

Related Experiment Videos